As we witness the rapidly climbing number of cases of coronavirus disease 2019 (COVID-
19), clinical trials are underway for monoclonal antibody treatments and a handful of …

Abstract The coronavirus disease 2019 (COVID-19) outbreak has become an evolving
global health crisis. With an increasing incidence of primary hypertension, there is greater …

Among the various comorbidities potentially worsening the clinical outcome in patients
hospitalized for the acute respiratory syndrome coronavirus-2 (SARS-CoV-2), hypertension …

Coronavirus disease 2019 (COVID-19) is caused by the virus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 can infect host cells by interacting …

Since the beginning of the twenty-first century, epidemic outbreaks of deadly pneumonia
have been caused by three coronaviruses: severe acute respiratory syndrome (SARS) …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible
for coronavirus disease 2019 (COVID-19) has been a major cause of morbidity and mortality …

Most striking observations in COVID-19 patients are the hints on pulmonary edema (also
seen on CT scans as ground glass opacities), dry cough, fluid restrictions to prevent more …

The world is currently suffering from the outbreak of a pandemic caused by the severe acute
respiratory syndrome coronavirus SARS-CoV-2 that causes the disease called COVID-19 …

Hypertension emerged from early reports as a potential risk factor for worse outcomes for
persons with coronavirus disease 2019 (COVID-19). Among the putative links between …

We are currently in the midst of a COVID-19 pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The global shutdown, with more than a …